The Design and Analysis of Stochastic Cost-Effectiveness Studies for the Evaluation of Health Care Interventions (original) (raw)

Abstract

Many clinical trials are in progress that involve the collection of patient-level data on both the health outcome and resource use consequences of the health care interventions under evaluation. The overall aim of many such evaluations will be to undertake a cost-effectiveness analysis, which will often result in a cost-effectiveness ratio summarizing the value for money of the intervention in question. In this paper, we explore the issues surrounding the design and analysis of such studies. At the design stage of an analysis, we propose an improved sample size formula for cost-effectiveness analysis that allows for covariance between cost and effect differences. This approach is based on the ‘net benefits’ approach to the analysis of uncertainty in cost-effectiveness analysis. At the analysis stage of an evaluation, we show that the net-benefit approach is equivalent to an appropriate analysis on the cost-effectiveness plane. We introduce the ‘cost-effectiveness acceptability curve’ as an alternative method for summarizing cost-effectiveness results that directly address the study question of whether an intervention is cost-effective.

Access this article

Log in via an institution

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Similar content being viewed by others

References

  1. Drummond M, O’Brien B. Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes. Health Econ. 1993;2:205–212.
    Article CAS Google Scholar
  2. O’Brien BJ, Drammond MF, Labelle RJ, Willan A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care. 1994;32:150–163.
    Article Google Scholar
  3. Sacristan JA, Day SJ, Navarro O, Ramos J, Hernandez JM. Use of confidence intervals and sample size calculations in health economic studies. Ann Pharmacother. 1995;29:719–725.
    Article CAS Google Scholar
  4. Coyle D. Statistical analysis in pharmacoeconomic studies. Pharmaco Econ. 1996;9:506–516.
    Article CAS Google Scholar
  5. Briggs AH, Gray AM. Sample size and power calculations for stochastic cost-effectiveness analysis. Med Decision Mak. 1998;18:S81–S92.
    Article CAS Google Scholar
  6. Tambour M, Zethraeus N, Johannesson M. A note of confidence intervals in cost-effectiveness analysis. Int J Tech Assess Health Care. 1998;14(3):467–471.
    Article CAS Google Scholar
  7. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decision Mak. 1998;18:S65–S80.
    Google Scholar
  8. van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994;3:309–319.
    Article Google Scholar
  9. Anderson JP, Bush JW, Chen M, Dolenc D. Policy space areas and properties of benefit-cost/utility analysis. JAMA. 1986;255:794–795.
    Article CAS Google Scholar
  10. Black WC. The CE plane: A graphic representation of cost-effectiveness. Med Decision Mak. 1990;10:212–214.
    Article CAS Google Scholar
  11. Karlsson G, Johannesson M. The decision rules of cost-effectiveness analysis. PharmacoEcon. 1996;9:113–120.
    Article CAS Google Scholar
  12. Wakker P, Klaassen M. Confidence intervals for cost-effectiveness ratios. Health Econ. 1995;4:373–382.
    Article CAS Google Scholar
  13. Chaudhary MA, Steams SC. Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial. Stat Med. 1996;15:1447–1458.
    Article CAS Google Scholar
  14. Willan AR, O’Brien BJ. Confidence intervals for cost-effectiveness ratios: an application of Fieller’s theorem. Health Econ. 1996;5:297–305.
    Article CAS Google Scholar
  15. Obenchain RL, Melfi CA, Croghan TW, Buesching DP. Bootstrap analyses of cost effectiveness in antidepressant pharmacotherapy. PharmacoEcon. 1997;11:464–472.
    Article CAS Google Scholar
  16. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6:327–340.
    Article CAS Google Scholar
  17. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
    Book Google Scholar
  18. Heitjan DF, Moskowitz AJ, Whang W. Problems with interval estimates of the incremental cost-effectiveness ratio. Med Decision Mak. 1999;19(1):9–15.
    Article CAS Google Scholar
  19. Briggs AH. A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ. 1999; 8(3).
    Google Scholar
  20. Heitjan DF, Moskowitz AJ, Whang W. Bayesian estimation of cost-effectiveness ratios from clinical trials. Health Econ. 1999;8(3):191–201.
    Article CAS Google Scholar
  21. O’Hagan A, Stevens JW, Montmartin J. Inference for the C/E acceptability curve and C/E ratio. PharmacoEcon. 2000;17:339–349.
    Article Google Scholar

Download references

Author information

Authors and Affiliations

  1. Health Economics Research Centre, Institute of Health Sciences, University of Oxford, Headington, Oxford, OX3 7LF, UK
    Andrew Briggs
  2. Centre for Health Economics, Department of Economics, Stockholm School of Economics, Stockholm, Sweden
    Magnus Tambour

Authors

  1. Andrew Briggs
  2. Magnus Tambour

Corresponding author

Correspondence to Andrew Briggs.

Rights and permissions

About this article

Cite this article

Briggs, A., Tambour, M. The Design and Analysis of Stochastic Cost-Effectiveness Studies for the Evaluation of Health Care Interventions.Ther Innov Regul Sci 35, 1455–1468 (2001). https://doi.org/10.1177/009286150103500441

Download citation

Key Words